Back to Clinical Trials

Clinical Trials: Medical Research


Source: Sucampo Pharma Americas, LLC
The primary purpose of the study is to evaluate the efficacy and safety of lubiprostone administration in subjects with OBD. Read More
Last Updated: 31 Jan 2013
Source: AstraZeneca
This multicenter, open-label extension study of Protocol 2993-112 is designed to assess long-term glucose control as measured by HbA1c (glycosylated hemoglobin) and to evaluate long-term safety and tolerability in subjects treated with metformin who receive subcutaneously injected AC2993 (10 mcg) administered twice daily. Subjects completing Protocol 2993-112 are eligible to enroll. Read More
Last Updated: 22 Feb 2015
Source: Pfizer
To answer the question of overall benefit: risk of celecoxib when compared to two most commonly prescribe traditional (non-selective) nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of arthritis pain. For this purpose, patients with osteoarthritis or rheumatoid arthritis with or at risk of developing cardiovascular disease will be recruited. The cardiovascular, gastrointestinal and renal safety and symptomatic benefit in each treatment group ... Read More
Last Updated: 24 Jul 2016
Source: Pfizer
A4091064 is a multicenter, long-term observational study of subjects from tanezumab interventional studies (regardless of treatment group) who undergo a total knee, hip or shoulder replacement during participation in the study. The study is designed with a total duration of subject follow-up of 24 weeks after the total joint replacement surgery. There will be two methods of data collection utilized in this study: interview by site staff via the telephone and ... Read More
Last Updated: 17 Jan 2017
Source: Novartis
This is a 2-3 period parallel group study with an adaptive element in Type 2 diabetes patients receiving vildagliptin as monotherapy. Read More
Last Updated: 01 Jan 2013
Source: Abbott Nutrition
Evaluate effects of an oral nutritional supplement on healthcare outcomes in older hospitalized adults. Also referred to as the NOURISH Study - Nutrition effect On Unplanned Readmissions and Survival in Hospitalized patients. Read More
Last Updated: 23 Apr 2015
Source: Tioga Pharmaceuticals
The purpose of this study is to evaluate the safety and efficacy of different doses of asimadoline in the treatment of patients with irritable bowel syndrome. Read More
Last Updated: 16 Oct 2011
Source: Mannkind Corporation
Pulmonary Safety in Diabetics with T/I Read More
Last Updated: 08 Oct 2014
Source: Sucampo Pharma Americas, LLC
The primary purpose of this study is to evaluate the efficacy and safety of lubiprostone administration in patients with opioid-induced bowel dysfunction (OBD). Read More
Last Updated: 01 Nov 2015
Source: BioCryst Pharmaceuticals
The purpose of this study is to determine whether peramivir is safe and effective in the treatment of uncomplicated seasonal influenza. Read More
Last Updated: 11 Feb 2015
Source: Novartis
This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of hand osteoarthritis. Read More
Last Updated: 12 Apr 2015
Source: Pfizer
The purpose of this study is to compare the long-term joint safety and efficacy (pain relief) of the investigational study drug, tanezumab compared to non-steroidal anti inflammatory drugs (NSAIDs) in subjects with osteoarthritis of the hips or knees. Read More
Last Updated: 16 Jan 2017
Source: Targacept Inc.
Overactive bladder (OAB) is a syndrome characterized by symptoms of a sudden need to urinate with or without incontinence (leaking). The purpose of this study is to test whether dexmecamylamine is safe and effective compared to placebo for the treatment of symptoms of OAB. Read More
Last Updated: 10 May 2015
Source: Pfizer
The purpose of the research study is to find out if opioid dependent chronic pain patients who are judged by their physician to be eligible to change their current opioid medicine and to participate in this study can be successfully adjusted to a stable dose of EMBEDA (morphine sulfate and naltrexone hydrochloride). The study will also assess each patient's risk for prescription opioid abuse, misuse and diversion. Read More
Last Updated: 08 Oct 2012
Source: Ferring Pharmaceuticals
The purpose of this study is to investigate the efficacy and safety of several doses of the melt formulation of desmopressin in a broad population of adult patients with nocturia. Read More
Last Updated: 28 Sep 2015
Source: Dynogen Pharmaceuticals
This study will evaluate the safety and effectiveness of the investigational drug DDP733 in treating female patients with IBS-c. A placebo control will be utilized. Read More
Last Updated: 06 Apr 2008
Source: Mannkind Corporation
The main purpose of the trial is to evaluate pulmonary function in subjects who had completed any one of the 4 MKC parent trials (MKC-TI-009, MKC-TI-102, MKC-TI-103, or MKC-TI-030) for an additional 2-month safety follow-up. Read More
Last Updated: 30 Nov 2014
Source: Pfizer
This study is a multicenter, randomized study in subjects with high cholesterol receiving highly effective statins to assess the efficacy, safety and tolerability of Bococizumab (PF-04950615;RN316) to lower LDL-C. Read More
Last Updated: 22 Aug 2016
Source: Gilead Sciences
This study will evaluate the efficacy, safety, and tolerability of selonsertib (formerly GS-4997) in participants with diabetic kidney disease (DKD). Participants will be randomized with a 1:1:1:1 allocation to receive 1 of 3 doses of selonsertib (2 mg, 6 mg, or 18 mg) or matching placebo. Read More
Last Updated: 11 Jan 2017
Source: Novartis
The trial is designed to identify an appropriate dose of QAB149 for delivery via a multiple dose inhaler for use in the COPD Phase III program. Read More
Last Updated: 23 Oct 2011
Page 1 of 50